Bastiano Sanna - Net Worth and Insider Trading
Bastiano Sanna Net Worth
The estimated net worth of Bastiano Sanna is at least $16 Million dollars as of 2024-11-13. Bastiano Sanna is the EVP, Cell & Genetic Therapies of Vertex Pharmaceuticals Inc and owns about 32,038 shares of Vertex Pharmaceuticals Inc (VRTX) stock worth over $16 Million. Details can be seen in Bastiano Sanna's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Bastiano Sanna has not made any transactions after 2023-05-08 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Bastiano Sanna
Bastiano Sanna Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Bastiano Sanna owns 2 companies in total, including Vertex Pharmaceuticals Inc (VRTX) , and Adicet Bio Inc (ACET) .
Click here to see the complete history of Bastiano Sanna’s form 4 insider trades.
Insider Ownership Summary of Bastiano Sanna
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| VRTX | Vertex Pharmaceuticals Inc | 2023-05-08 | EVP & Cell & Genetic Therapies |
| ACET | Adicet Bio Inc | 2020-12-01 | director |
Bastiano Sanna Latest Holdings Summary
Bastiano Sanna currently owns a total of 1 stock. Bastiano Sanna owns 32,038 shares of Vertex Pharmaceuticals Inc (VRTX) as of May 8, 2023, with a value of $16 Million.
Latest Holdings of Bastiano Sanna
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| VRTX | Vertex Pharmaceuticals Inc | 2023-05-08 | 32,038 | 490.00 | 15,698,620 |
Holding Weightings of Bastiano Sanna
Bastiano Sanna Form 4 Trading Tracker
According to the SEC Form 4 filings, Bastiano Sanna has made a total of 20 transactions in Vertex Pharmaceuticals Inc (VRTX) over the past 5 years, including 0 buys and 20 sells. The most-recent trade in Vertex Pharmaceuticals Inc is the sale of 3,272 shares on May 8, 2023, which brought Bastiano Sanna around $1 Million.
Insider Trading History of Bastiano Sanna
- 1
Bastiano Sanna Trading Performance
Bastiano Sanna Ownership Network
Ownership Network List of Bastiano Sanna
Ownership Network Relation of Bastiano Sanna
Bastiano Sanna Owned Company Details
What does Vertex Pharmaceuticals Inc do?
Who are the key executives at Vertex Pharmaceuticals Inc?
Bastiano Sanna is the EVP & Cell & Genetic Therapies of Vertex Pharmaceuticals Inc. Other key executives at Vertex Pharmaceuticals Inc include EVP and Chief Legal Officer Jonathan Biller , EVP and CMO Carmen Bozic , and director & CEO & President Reshma Kewalramani .
Vertex Pharmaceuticals Inc (VRTX) Insider Trades Summary
Over the past 18 months, Bastiano Sanna made no insider transaction in Vertex Pharmaceuticals Inc (VRTX). Other recent insider transactions involving Vertex Pharmaceuticals Inc (VRTX) include a net sale of 47,585 shares made by Carmen Bozic , a net sale of 16,533 shares made by Ourania Tatsis , and a net sale of 77,232 shares made by Reshma Kewalramani .
In summary, during the past 3 months, insiders sold 5,429 shares of Vertex Pharmaceuticals Inc (VRTX) in total and bought 0 shares, with a net sale of 5,429 shares. During the past 18 months, 340,041 shares of Vertex Pharmaceuticals Inc (VRTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 340,041 shares.
Vertex Pharmaceuticals Inc (VRTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Vertex Pharmaceuticals Inc Insider Transactions
Bastiano Sanna Mailing Address
Above is the net worth, insider trading, and ownership report for Bastiano Sanna. You might contact Bastiano Sanna via mailing address: C/o Vertex Pharmaceuticals Incorporated, 50 Northern Avenue, Boston Ma 02210.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
